Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ataciguat for chronic neuropathic pain
2008-001518-26Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ataciguat in Neuralgia (2 arms), sponsored by Sanofi. Primary endpoint: Pain intensity reduction. Started Jun 2008; status: completed.
02
Drugs
ataciguat
03
Conditions
Neuralgia
Beyond the preview
Go deeper on 2008-001518-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001518-26.